Acurx Pharmaceuticals, Inc. (ACXP) ownership: Top institutional holder: JANE STREET GROUP, LLC ($202722.00). Insider activity: Net Seller (0 buys, 20 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| JANE STREET GROUP, LLC | 54642.00 | $202722.00 | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31099.00 | $115377.00 | 2026-03-31 |
| MILLENNIUM MANAGEMENT LLC | 41427.00 | $103153.00 | 2025-12-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 24819.00 | $92080.00 | 2026-03-31 |
| Cambridge Investment Research Advisors, Inc. | 20000.00 | $74000.00 | 2026-03-31 |
| VANGUARD FIDUCIARY TRUST CO | 16205.00 | $60121.00 | 2026-03-31 |
| VANGUARD GROUP INC | 23280.00 | $57967.00 | 2025-12-31 |
| Prospect Financial Services LLC | 13785.00 | $51144.00 | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-04-20 | |
| Sell | null | 2026-04-20 | |
| Sell | null | 2026-04-20 | |
| Sell | null | 2026-04-20 | |
| Sell | null | 2026-04-20 | |
| Sell | null | 2026-04-20 | |
| Sell | null | 2026-04-20 | |
| Sell | null | 2026-04-20 |
Back to ACXP overview · ACXP earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.